OPN5

Across TCGA pan-cancer cohorts, OPN5 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated OPN5 data layer compared with 16 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher OPN5 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated OPN5 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and LSCC show a favorable association.

CCRCC, LSCC, and GBM are the cancer types where OPN5 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Median	III,IV	0.904	0.105	.008	23	view →
LSCC	DFS	Tertile	III,IV	1.000	0.625	.024	3	view →
GBM	OS	Tertile	All	0.747	0.968	.016	1	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

OPN5–CCRCC (DFS)

Open the CCRCC breakdown →